Cat Lawyer Uses Viral Internet Fame to Lend Nonprofit Support
February 25, 2021 10:43 ET
|
Rod Ponton, Attorney at Law
Pecos, Texas, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Rod Ponton, the Texas-based lawyer whose video went viral after he was stuck in a cat filter during an online call, is using his internet fame to...
Children’s Mercy Kansas City Expands Investment in Pacific Biosciences Sequel IIe Systems to Scale Up Whole Genome Research Initiatives Focused on Rare Disease Diagnosis
February 24, 2021 08:00 ET
|
Pacific Biosciences of California, Inc.
KANSAS CITY, Mo. and MENLO PARK, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms,...
European Commission Grants Ocugen Orphan Medicinal Product Designation for Gene Therapy Product Candidate, OCU400, For the Treatment of Both Retinitis Pigmentosa and Leber Congenital Amaurosis
February 23, 2021 07:30 ET
|
Ocugen
MALVERN, Pa., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc., (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness...
Saniona senarelägger publicering av bokslutskommuniké för 2020 till följd av omräkning och förnyad revision av tidigare finansiella rapporter för att uppfylla amerikanska revisionsstandarder
February 22, 2021 17:59 ET
|
Saniona AB
PRESSMEDDELANDE 22 februari 2021 Saniona (OMX: SANION), ett biofarmaceutiskt företag med klinisk utveckling fokuserad på sällsynta sjukdomar, meddelar idag att bolaget, som ett led i den tidigare...
Saniona postpones 2020 year-end financial report due to restatement and re-audit of prior period financial statements in line with U.S. PCAOB audit standards
February 22, 2021 17:59 ET
|
Saniona AB
PRESS RELEASE February 22, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that, as part of its previously announced...
Travere Therapeutics Announces Pricing of Public Offering of Common Stock
February 11, 2021 22:03 ET
|
Travere Therapeutics, Inc.
SAN DIEGO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced the pricing of an underwritten public offering of 6,550,000 shares of its common stock at a...
Travere Therapeutics Announces Proposed Public Offering of Common Stock
February 10, 2021 16:01 ET
|
Travere Therapeutics, Inc.
SAN DIEGO, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that it intends to offer and sell, in an underwritten public offering and subject to market and...
Inozyme Pharma Appoints Deborah Wenkert, M.D., as Senior Vice President and Chief Medical Officer
February 04, 2021 06:00 ET
|
Inozyme Pharma Inc.
BOSTON, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases of abnormal...
Crinetics Pharmaceuticals Advances CRN04777 for Congenital Hyperinsulinism into Phase 1 Study
February 03, 2021 07:10 ET
|
Crinetics Pharmaceuticals, Inc.
SAN DIEGO, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of...
Saniona har erhållit upfrontbetalning om cirka 2,9 miljoner USD (24,2 miljoner SEK) i samband med förvärvet av Cadent Therapeutics
January 25, 2021 08:00 ET
|
Saniona AB
PRESSMEDDELANDE 25 januari 2021 Saniona (OMX: SANION), ett biofarmaceutiskt företag med klinisk utveckling fokuserad på sällsynta sjukdomar, tillkännagav idag att Saniona tillförts cirka 2,9...